Association of IL-10 gene promoter polymorphisms with food allergy susceptibility and serum IL-10 level in a pediatric Caucasian population.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
04 2021
Historique:
revised: 29 10 2020
received: 20 09 2020
accepted: 02 11 2020
pubmed: 13 11 2020
medline: 19 8 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Interleukin 10 has been shown to play a critical role in the regulation of the immune responses in allergic diseases. To investigate if genetic polymorphisms in the promoter region of the IL-10 gene are associated with food allergy (FA) susceptibility in Caucasian pediatric patients with concomitant allergic diseases and IL-10 levels. The single nucleotide polymorphisms (SNPs) at -1082A > G (rs1800896), -819 T > C (rs1800871), and -592A > C (rs1800872) of 62 pediatric patients with IgE-mediated FA were analyzed and correlated with clinical parameters, serum IgE and IL-10 levels. The results were compared with those of 92 healthy controls without FA, personal and/or family history of atopy. Analysis and comparison of genotype distributions, allele frequencies, and haplotypes showed that none of the genotypes confers an increased risk of FA. The genotype -1082 AA in FA patients was associated with moderate to severe symptoms of FA, the development of atopic asthma, and higher levels of IL-10. In a linear regression study, we confirmed that the genotype -1082 AA acts as an independent factor for the higher levels of IL-10. A positive association was also observed between -819T/C and -592 A/C SNPs and later onset of FA. Polymorphisms in the promoter region of the IL-10 gene are not associated with FA susceptibility in our cohort. In FA patients, -1082 A/G SNPs seem to influence the production of IL-10, the severity of FA symptoms, and the development of atopic asthma in this population.

Sections du résumé

BACKGROUND
Interleukin 10 has been shown to play a critical role in the regulation of the immune responses in allergic diseases.
AIM
To investigate if genetic polymorphisms in the promoter region of the IL-10 gene are associated with food allergy (FA) susceptibility in Caucasian pediatric patients with concomitant allergic diseases and IL-10 levels.
METHODS
The single nucleotide polymorphisms (SNPs) at -1082A > G (rs1800896), -819 T > C (rs1800871), and -592A > C (rs1800872) of 62 pediatric patients with IgE-mediated FA were analyzed and correlated with clinical parameters, serum IgE and IL-10 levels. The results were compared with those of 92 healthy controls without FA, personal and/or family history of atopy.
RESULTS
Analysis and comparison of genotype distributions, allele frequencies, and haplotypes showed that none of the genotypes confers an increased risk of FA. The genotype -1082 AA in FA patients was associated with moderate to severe symptoms of FA, the development of atopic asthma, and higher levels of IL-10. In a linear regression study, we confirmed that the genotype -1082 AA acts as an independent factor for the higher levels of IL-10. A positive association was also observed between -819T/C and -592 A/C SNPs and later onset of FA.
CONCLUSION
Polymorphisms in the promoter region of the IL-10 gene are not associated with FA susceptibility in our cohort. In FA patients, -1082 A/G SNPs seem to influence the production of IL-10, the severity of FA symptoms, and the development of atopic asthma in this population.

Identifiants

pubmed: 33179333
doi: 10.1111/pai.13407
doi:

Substances chimiques

IL10 protein, human 0
Interleukin-10 130068-27-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

552-559

Informations de copyright

© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Sicherer SH, Sampson HA. Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41-58. https://doi.org/10.1016/j.jaci.2017.11.003
Blázquez AB, Berin MC. Microbiome and food allergy. Transl Res. 2017;179:199-203. https://doi.org/10.1016/j.trsl.2016.09.003
Tordesillas L, Berin MC. Mechanisms of Oral Tolerance. Clin Rev Allergy Immunol. 2018;55(2):107-117. https://doi.org/10.1007/s12016-018-8680-5
Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015;367(2):103-107. https://doi.org/10.1016/j.canlet.2015.07.009
Powell MJ, Thompson SA, Tone Y, Waldmann H, Tone M. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region. J Immunol. 2000;165(1):292-296.
Mucida D. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest. 2005;115(7):1923-1933. https://doi.org/10.1172/JCI24487
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1-8.
Yilmaz V, Yentür SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine. 2005;30(4):188-194. https://doi.org/10.1016/j.cyto.2005.01.006
Zhao J, Chen Z-Y, Li L-F. Association between the IL-10-1082G/A, IL-10-592A/C, and IL-10-819G/A polymorphisms and atopic dermatitis susceptibility: a meta-analysis. Genet Test Mol Biomarkers. 2019;23(5):332-341. https://doi.org/10.1089/gtmb.2018.0276
Huang ZY, Cheng BJ, Wan Y, Zhou C. Meta-analysis of the IL-10 promoter polymorphisms and pediatric asthma susceptibility. Genet Mol Res. 2016;15(2). https://doi.org/10.4238/gmr.15028320
Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025. https://doi.org/10.1111/all.1242
Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1-58 https://doi.org/10.1016/J.JACI.2010.10.007
Anvari S, Miller J, Yeh C-Y, Davis CM. IgE-Mediated Food Allergy. Clin Rev Allergy Immunol. 2019; 57(2):244-260. https://doi.org/10.1007/s12016-018-8710-3
Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996;184(1):19-29.
Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood. 2005;105(3):1162-1169. https://doi.org/10.1182/blood-2004-03-1211
Punnonen J, de Waal MR, van Vlasselaer P, Gauchat JF, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol. 1993;151(3):1280-1289.
Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol. 1993;151(5):2390-2398.
Campos Alberto EJ, Shimojo N, Suzuki Y, et al. IL-10 gene polymorphism, but not TGF-beta1 gene polymorphisms, is associated with food allergy in a Japanese population. Pediatr Allergy Immunol. 2008;19(8):716-721. https://doi.org/10.1111/j.1399-3038.2007.00709.x
Jacob CMA, Pastorino AC, Okay TS, et al. Interleukin 10 (IL10) and transforming growth factor β1 (TGFβ1) gene polymorphisms in persistent IgE-mediated cow's milk allergy. Clinics (Sao Paulo). 2013;68(7):1004-1009. https://doi.org/10.6061/clinics/2013(07)19
Chen T-K, Lee J-H, Yu H-H, et al. Association between human IL-10 gene polymorphisms and serum IL-10 level in patients with food allergy. J Formos Med Assoc. 2012;111(12):686-692. https://doi.org/10.1016/j.jfma.2011.11.027
Negoro T, Orihara K, Irahara T, et al. Influence of SNPs in cytokine-related genes on the severity of food allergy and atopic eczema in children. Pediatr Allergy Immunol. 2006;17(8):583-590. https://doi.org/10.1111/j.1399-3038.2006.00463.x
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the Interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1-8. https://doi.org/10.1111/j.1365-2370.1997.tb00001.x
Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RGJ, Huizinga TWJ. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA. 1998;95(16):9465-9470. https://doi.org/10.1073/pnas.95.16.9465
Tsiavou A, Hatziagelaki E, Chaidaroglou A, et al. TNF-α, TGF-β1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol. 2004;24(6):591-599. https://doi.org/10.1007/s10875-004-6239-0

Auteurs

Natalia Nedelkopoulou (N)

1st Department of Paediatrics, Paediatric Immunology and Rheumatology Referral Centre, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.
Pediatric Gastroenterology Department, Sheffield Children's Hospital Foundation Trust, Sheffield, UK.

Anna Taparkou (A)

1st Department of Paediatrics, Paediatric Immunology and Rheumatology Referral Centre, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.

Sofia Raftopoulou (S)

Laboratory of Immunology and Histocompatibility, Department of Medicine, University of Thessaly, Larisa, Greece.

Dimos Gidaris (D)

1st Department of Paediatrics, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.
University of Nicosia, Nicosia, Cyprus.

Ioannis Xinias (I)

3rd Department of Paediatrics, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.

Antigoni Mavroudi (A)

3rd Department of Paediatrics, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.

Anil Dhawan (A)

Pediatric Liver, GI and Nutrition Centre, King's College Hospital and MowatLabs, London, UK.

Evangelia Farmaki (E)

1st Department of Paediatrics, Paediatric Immunology and Rheumatology Referral Centre, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH